Nomegestrol acetate/estradiol (NOMAC-E2), sold under the brand names Naemis and Zoely among others, is a fixed-dose combination medication of nomegestrol acetate, a progestogen, and estradiol, an estrogen, which is used in menopausal hormone therapy and as a birth control pill to prevent pregnancy in women.[3] It is taken by mouth.
Combination of | |
---|---|
Nomegestrol acetate | Progestogen |
Estradiol | Estrogen |
Clinical data | |
Trade names | Zoely |
Other names | NOMAC-E2, NOMAC/E2, MK-8175A |
AHFS/Drugs.com | UK Drug Information |
Routes of administration | By mouth |
Drug class | Estrogen; Progestogen |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
PubChem CID | |
KEGG |
Research
editEstradiol-containing birth control pills like NOMAC-E2 may have a lower risk of venous thromboembolism than birth control pills containing ethinylestradiol.[4] This is being studied in the case of NOMAC-E2.[4][5]
See also
editReferences
edit- ^ "Zoely 2.5 mg/1.5 mg film-coated tablets - Summary of Product Characteristics (SmPC)". (emc). 20 July 2020. Retrieved 9 June 2021.
- ^ "Zoely EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 9 June 2021.
- ^ Yang LP, Plosker GL (October 2012). "Nomegestrol acetate/estradiol: in oral contraception". Drugs. 72 (14): 1917–28. doi:10.2165/11208180-000000000-00000. PMID 22950535. S2CID 44335732.
- ^ a b Douxfils J, Morimont L, Bouvy C (October 2020). "Oral Contraceptives and Venous Thromboembolism: Focus on Testing that May Enable Prediction and Assessment of the Risk". Semin Thromb Hemost. 46 (8): 872–886. doi:10.1055/s-0040-1714140. PMID 33080636. S2CID 224821517.
- ^ "Results from large-scale real-world safety study for oral combination contraception pill, Zoely (NOMAC-E2), submitted to European Medicines Agency". Theramex (Press release). 27 April 2021. Retrieved 9 June 2021.
External links
edit- "Estradiol mixture with nomegestrol acetate". Drug Information Portal. U.S. National Library of Medicine.